spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  breakthrough cancer pain 

 HSMN NewsFeed - 23 Aug 2017
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 12 Jul 2017
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA(R) In Canada
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 30 May 2017
Churchill Pharmaceuticals Expands Commercial Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 Aug 2015
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jul 2013
BioDelivery Sciences Announces Regulatory Approval of ONSOLIS in Taiwan
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 1 May 2013
William L. Ashton Joins Galena Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jan 2012
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Feb 2010
Orexo Announces That Partner Kyowa Hakko Kirin Entered a Joint Distribution Agreement on KW-2246 for Treatment of Cancer Pain in Japan
Biopharmaceuticals Distribution
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Sep 2009
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2009
Akela Pharma Announces Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jan 2009
Meda Acquires World-Wide Rights to Onsolis
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Dec 2008
Prostrakan and Paladin Complete Agreement for Abstral(R) and Sancuso(R)
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Dec 2008
Abstral receives marketing approval in Germany
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Apr 2008
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Mar 2008
Orexo: Rapinyl(TM) has Received Swedish Marketing Authorization
Biopharmaceuticals Regulatory Drug Delivery
 HSMN NewsFeed - 24 Jan 2008
Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Jan 2008
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 19 Dec 2007
Javelin Pharmaceuticals Announces Peer-Reviewed Publication of Successful Postoperative Pain Trial with PMI-100/150 (Intranasal Ketamine) in International Journal, ''Acute Pain''
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Dec 2007
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Sep 2007
Orexo: Orexo's Rapinyl(TM) Nearing Regulatory Decision in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
Biopharmaceuticals Oncology Pain Management
 HSMN NewsFeed - 5 Sep 2007
AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
Biopharmaceuticals Drug Delivery Pain Management
 HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Biopharmaceuticals
 HSMN NewsFeed - 12 Jul 2007
LAB International announces name change to Akela Pharma Inc.
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 10 Apr 2007
BioDelivery Sciences Names Al Medwar as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2006
Endo Pharmaceuticals Acquires RxKinetix, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2006
Barr Launches Generic ACTIQ(R) Cancer Pain Management Product
Biopharmaceuticals Generics Drug Delivery
 HSMN NewsFeed - 1 May 2006
Javelin Announces Initial Results of a Pilot Phase II Study Of Intranasal Ketamine In Postoperative Orthopedic Pain
 HSMN NewsFeed - 26 Jan 2006
YM Biosciences' subsidiary DELEX Therapeutics announces enrollment of first patient in Phase IIb trial for the treatment of acute pain with AeroLEF(TM)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jan 2006
BioDelivery Sciences Hires Proven Pharmaceutical Executive To Head Sales and Marketing Effort
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2006
BioDelivery Sciences Files IND for BEMA(TM) LA, a Treatment for Moderate to Severe Pain
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 22 additional stories matching:
breakthrough cancer pain
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.